Moret Karin, Beerenhout Charles H, van den Wall Bake A Warmold L, Gerlag Paul G, van der Sande Frank M, Leunissen Karel M, Kooman Jeroen P
Department of Internal Medicine, Máxima Medical Centre, Veldhoven, The Netherlands.
Nephrol Dial Transplant. 2007 Aug;22(8):2276-82. doi: 10.1093/ndt/gfm108. Epub 2007 Jun 5.
Ionic dialysance was recently introduced as a means to assess Kt/V (K(ID)t/V). With this method, urea distribution volume (V) has to be estimated. The primary aim of the present study was to assess the agreement between equilibrated Kt/V assessed by urea kinetic modelling (eKt/V) with K(ID)t/V taking into account different estimates of V, and to assess the monthly variation in V. Secondly, the mechanisms behind the intra-treatment changes in ionic dialysance and inter-treatment variability of K(ID)t/V were assessed.
Sixty-six patients were included. eKt/V was estimated using 30 min post-treatment sampling in the second generation Daugirdas equation. V was assessed by the formulae of Watson and Chertow (V(Watson); V(Chertow)), double-pool urea kinetic modelling (V(UKM)) and by ionic dialysance (V(IOD)) [Diascan; Hospal(R)].
The use of V(UKM) or V(IOD) instead of V(Watson) or V(Chertow) improved the relation between eKt/V and K(ID)t/V (both r = 0.93; P < 0.001 vs r = 0.84 and r = 0.81; P < 0.001). Mean values of eKt/V (1.19 +/- 0.21), K(ID)t/V(UKM) (1.19 +/- 0.30) and K(ID)t/V(IOD) (1.21 +/- 0.25) were comparable. Intra-class correlation coefficient of V(IOD) was 0.87 with a 1-month interval and <0.75 after 2 and 3 months. Intra-class correlation coefficient of V(DP) was 0.79 with a 1-month interval and <0.75 after 2 and 3 months. Inter-treatment variation in K(ID)t/V during six consecutive dialysis sessions was 6.1% +/- 0.6%. Changes in blood flow were the main determinant of variations in K(ID)t/V (P < 0.05). During treatment, ionic dialysance decreased by 12 +/- 13 ml/min (P < 0.001). The decline in blood volume was the major determinant of the intra-dialytic change in ionic dialysance (P < 0.05).
The use of V(IOD) and V(UKM) results in better agreement between eKt/V and K(ID)t/V compared with anthropometric formulae. K(ID)t/V was comparable with eKt/V and thus lower than expected for a single-pool method. V(IOD) and V(UKM), should be assessed at least monthly. K(ID)t/V varies widely between consecutive dialysis sessions, mainly due to differences in blood flow. During treatment, ionic dialysance decreases, which is related to the relative decline in blood volume.
离子透析法最近被引入作为评估Kt/V(K(ID)t/V)的一种手段。采用这种方法时,必须估计尿素分布容积(V)。本研究的主要目的是评估在考虑不同V估计值的情况下,通过尿素动力学模型评估的平衡Kt/V(eKt/V)与K(ID)t/V之间的一致性,并评估V的月度变化。其次,评估了离子透析治疗期间变化及K(ID)t/V治疗间变异性背后的机制。
纳入66例患者。使用第二代Daugirdas方程中治疗后30分钟的采样来估计eKt/V。通过Watson和Chertow公式(V(Watson);V(Chertow))、双池尿素动力学模型(V(UKM))以及离子透析法(V(IOD))[Diascan;Hospal(R)]来评估V。
使用V(UKM)或V(IOD)而非V(Watson)或V(Chertow)可改善eKt/V与K(ID)t/V之间的关系(两者r = 0.93;P < 0.001,相比之下r = 0.84和r = 0.81;P < 0.001)。eKt/V(1.19 ± 0.21)、K(ID)t/V(UKM)(1.19 ± 0.30)和K(ID)t/V(IOD)(1.21 ± 0.25)的平均值具有可比性。V(IOD)的组内相关系数在间隔1个月时为0.87,在2个月和3个月后<0.75。V(DP)的组内相关系数在间隔1个月时为0.79,在2个月和3个月后<0.75。连续6次透析治疗期间K(ID)t/V的治疗间变异为6.1% ± 0.6%。血流量变化是K(ID)t/V变异的主要决定因素(P < 0.05)。治疗期间,离子透析率下降了12 ± 13 ml/分钟(P < 0.001)。血容量下降是离子透析率透析内变化的主要决定因素(P < 0.05)。
与人体测量公式相比,使用V(IOD)和V(UKM)可使eKt/V与K(ID)t/V之间具有更好的一致性。K(ID)t/V与eKt/V具有可比性,因此低于单池法预期值。应至少每月评估一次V(IOD)和V(UKM)。连续透析治疗期间K(ID)t/V差异很大,主要是由于血流量不同。治疗期间,离子透析率降低,这与血容量的相对下降有关。